FIND in the news

Year: Program:

Links to news items can only be guaranteed on date of publication.

2014

Bioresearch Online, 25 March 2014

New tests can diagnose TB within two hours, while older diagnostic tests could take as long as three months to produce an accurate result. The WHO partnered with the Foundation for Innovative New Diagnostics for the Expand-TB project. The Foundation will provide screening technology to middle and low income countries affected by TB.

Scientific American, 24 March 2014

For example, non-profits such as the Foundation for Innovative New Diagnostics, the TB Alliance and Aeras have recently established themselves as key global participants in the pursuit of new TB diagnostics, drugs and vaccines, respectively.

All Africa, 21 March 2014

The machine is small about the size of a microwave oven and can fit easily on a small table. It was developed in the United States by a company called Cepheid and an organisation called the Foundation for Innovative New Diagnostics (FIND), supported by the American National Institutes of Health.

New Vision - Uganda, 20 March 2014

According to Dr. Charles Wamboga, the in-charge of sleeping sickness at the ministry of health, the break has come as a result of intensive suppression methods supported by different stakeholders. “To sustain this reduction, government with support from Foundation for Innovative New Diagnostics (FIND), is strengthening case detection for sleeping sickness in the north-west region,” he said. He said further that the partnership caused the increase of diagnostic centres in West Nile from four to 200 centres while FIND plans to expand services to South Sudan in order to stop re-infestation as the tsetse fly is trans-boundary in nature. “Given the severity and fatality associated with sleeping sickness, there is still need to continue surveillance efforts,” warned Wamboga

Med-Tech Innovation, 03 January 2014

Patients may not stay in one place very long Patients can include a large proportion of transitory or dispersed populations with no formal ID or address, which means fast turnarounds and good sample tracking are essential. For example, one of the main drivers for a new Malaria screening test, developed by the Foundation for Innovative New Diagnostics (www.finddiagnostics.org), is use of localised high throughput processing in the field. Samples are collected, tested and treatment is issued within one day to ensure the best chance of finding positive patients again. GPS tracking is also increasingly used during sample collection to log the patient’s exact location (typically in their home) and enabling them to be more easily located for treatment; the technology is also invaluable in monitoring the geographical spread of disease.

2013

reliefweb, 17 December 2013

The report, a collaboration between the Foundation for Innovative New Diagnostics, Medicines for Malaria Venture, Path Malaria Vaccine Initiative and Innovative Vector Control Consortium, noted that at least $700 million is needed annually to develop necessary tools to combat the disease.

allAfrica, 21 September 2013

Launch of new diagnosis: Government, in partnership with Foundation for Innovative New Diagnostics (FIND), recently launched a new rapid innovation to be used with ease and regarded to be highly sensitive.

wired-gov.net, 19 September 2013

A new implementation guide provides the tools to develop well-planned strategies for using rapid diagnostic testing in Malaria control programmes. Earlier this year the Foundation for Innovative New Diagnostics (FIND) published an implementation guide for rapid diagnostic tests (RDTs).

Modern Ghana, 18 September 2013

Dr Min Than Nyunt, Director General, Department of Health, Myanmar said to Citizen News Service - CNS that the Foundation for Innovative New Diagnostics (FIND) and UNITAID have helped strengthen laboratory capacity in the country. Now, there are two reference laboratories (national TB reference laboratory in Yangon and regional TB reference laboratory in Mandalay) which are fully equipped with BSL III laboratories and latest TB diagnostic tools such as Gene Xpert MTB/RIF, Line Probe Assays (LPA), liquid and solid culture testing, among others.

HLN.be, 11 September 2013

Ook de Foundation for Innovative New Diagnostics (FIND) in Genève en het Zuid-Koreaanse Standard Diagnostics Inc. (SD) ontwikkelden mee de test.

Cambridge Network, 29 July 2013

This deal follows a series of milestones for Lumora this year, including a deal with Biogal to provide veterinary diagnostics, a partnership with FIND (Foundation for Innovative New Diagnostics) to develop a novel malaria diagnostic, a new fundraising round and the appointment of new team members including a new commercial director and Chairman.

London School of Hygiene & Tropical Medicine, 17 May 2013

The first study, led in London by the Hospital for Tropical Diseases (HTD), the London School of Hygiene & Tropical Medicine and the Foundation for Innovative New Diagnostics (FIND), compared LAMP to existing laboratory diagnostic methods on 705 blood samples of suspected imported malaria cases in the UK.

Fierce Medical Devices, 13 May 2013

A number of researchers and companies are focused on developing new diagnostics for the developing world that address malaria and other infectious diseases. Last month the U.K.'s Lumora, a molecular diagnostic company, disclosed it would work with the Foundation for Innovative New Diagnostics to develop a malaria assay. The technology at play will also be able to test for a broader menu of diseases, including HIV.

Health Systems Trust, 25 April 2013

Dr David Bell from the Foundation for Innovative New Diagnostics (FIND) said: “Most people who die of infectious diseases in malaria affected countries do so because they are given the wrong medicine, or the right medicine too late. Senegal saved over a million dollars-worth of antimalarial drugs in the first few years after introducing the tests.”

Device Space, 24 April 2013

MBio Diagnostics, Inc., a medical device company, and Foundation for Innovative New Diagnostics, or FIND, have announced the completion of Phase I of tuberculosis, or TB, serology feasibility program.

Fierce Medical Devices, 18 April 2013

They're focused on developing such a diagnostic that could screen for parasitemia malaria infections that would otherwise be hidden or at very low levels. One recently unveiled test accomplishes this--a collaboration between the Foundation for Innovative New Diagnostics and Eiken Chemical in Japan, the announcement notes.

Fierce Medical Devices, 17 April 2013

Cambridge, UK, Wednesday 17 April 2013 ... Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, has partnered with The Foundation for Innovative New Diagnostics (FIND) to develop a rapid, high-throughput malaria diagnostic assay for screening patients in the developing world.

The Asian Tribune, 11 April 2013

Out of 27 Gene Xpert MTB/RIF machines currently in use in Viet Nam, 17 were funded by TB CARE I, 5 by TB REACH, 2 by Canadian International Development Agency (CIDA), 1 by Oxford University Clinical Research Unit (OUCRU), 1 by PANTHER, 1 by Foundation for Innovative New Diagnostics (FIND).

National Bureau of Asian Research, 27 March 2013

An interview with Dr. Madhukar Pai reporting on promising recent developments in the global efforts to eliminate TB. For the first time, a rapid, cartridge-based, automated molecular test—the Xpert MTB/RIF test—is being scaled up for diagnosis of mycobacterium tuberculosis and detection of drug-resistance to rifampicin in more than 20 countries. The Xpert MTB/RIF technology was developed with the support of the Foundation for Innovative New Diagnostics (FIND) and endorsed by the World Health Organization in 2010. There is good evidence supporting its high accuracy. Since then, over 1,900,000 Xpert MTB/RIF cartridges have been procured worldwide in the public sector in 77 of the 145 countries eligible for concessional pricing of $9.98 per cartridge.

optics.org, 22 March 2013

Zeiss is itself a member of WHO’s Stop TB initiative, which was founded in 2006 with the aim of eliminating the disease by 2050. The Germany-headquartered company developed Primo Star iLED with the Swiss Foundation for Innovative New Diagnostics (FIND), and the microscope is made available to health facilities in the worst-hit countries at a greatly reduced price.

The Hindu, 09 February 2013

Dr. Rahul Narang of Foundation for Innovative New Diagnostics (FIND) explained about LPA and conducted a demonstration which was relayed live on CCTV from the CDST Lab.

Asian Tribune, 02 February 2013

Researchers, from the Cochrane Infectious Diseases Group, McGill University and the Foundation for Innovative New Diagnostics (FIND), analysed data from 18 studies, spread over 27 distinct centres, and involving a total of 7,816 adults supposed to be having pulmonary TB or multidrug-resistant TB (MDR-TB) -- with or without HIV infection -- with a view to assess the diagnostic accuracy of the Xpert ® MTB/RIF test -- a rapid, automated diagnostic test endorsed by the World Health Organization (WHO) in 2010 that simultaneously detects TB and resistance to rifampicin, as an indicator of multidrug-resistance.

The Scientist, 10 January 2013

Recognizing this need, the Foundation for Innovative New Diagnostics (FIND) was created in 2003 as a Product Development Partnership (PDP). Its mission is to develop and deliver innovative and affordable POC diagnostic tests for poverty-associated diseases, such as tuberculosis, malaria, sleeping sickness, leishmaniasis, and Chagas disease.

Cambridge Network, 07 January 2013

The Foundation for Innovative New Diagnostics (FIND), which is driving the development and early implementation of diagnostic tests for tuberculosis (TB), malaria and other diseases of the developing world, is extending its existing development partnership with 42 Technology (42T).

2012

MIT Technology Review, 11 December 2012

A practical, quick, and powerful diagnostic tool could change that deadly dynamic. Brought to market by a public-private partnership between the University of Medicine and Dentistry of New Jersey, the Foundation for Innovative New Diagnostics in Geneva, Switzerland, and Cepheid, a manufacturer based in Sunnyvale, California, the GeneXpert TB detection machine gained approval from the WHO in December 2010. A few months later, South Africa’s health minister, Aaron Motsoaledi, compared the machines to “bazookas” in the war against TB and pledged to place them in each of the country’s 52 districts.

Health.india.com, 23 November 2012

Overall, 6.6% of 4,400s diagnosed TB patients in the city, conducted at 18 clinics nationwide, were found to be drug resistant, an officer of the Foundation for Innovative New Diagnostics said.

Nagaland Post, 15 November 2012

Cartridge Based Nucleic Acid Amplification Test (CBNAAT) endorsed by World Health Organization is now available at district TB centre, Kohima for diagnosis of MDR TB (Multi Drug Resistant) patients. The CB-NAAT laboratory is one of the 11 labs operating in India under EXPAND TB project. The project is being facilitated by FIND (Foundation for Innovative New Diagnostics) agency specifically grass root level in the country.

Medical Physics Web, 12 November 2012

David Bell, a malaria expert at the Foundation for Innovative New Diagnostics in Geneva, is a little more reserved. "It is difficult to tell at this stage," he cautions, describing existing rapid-diagnostic tests as "adequate for case management". To make an impact, he feels the new test will need to be "equally cheap, robust, without lots of moving parts, and not need batteries. That is a difficult ask".

All Africa, 19 October 2012

Ahead of the release of the WHO report, the non-profit organization TB Alliance announced a partnership with the Foundation for Innovative New Diagnostics (FIND) to co-ordinate the development of mechanisms to fight MDR-TB and identify emerging drug resistance trends around the globe.

Noodls, 18 October 2012

Representatives from 21 countries in the Region, mainly those where TB is a high priority, discussed issues including quality control, biosafety, and the implementation and scale-up of rapid diagnosis of M/XDR. The participants also included representatives of WHO's Global laboratory Initiative (GLI), the Foundation for Innovative New Diagnostics (FIND) and the European Reference Laboratory Network for TB.

Euraka Alert, 17 October 2012

The partnership between the Foundation for Innovative New Diagnostics (FIND), which is driving the development and early implementation of diagnostic tests for TB and other diseases of the developing world, and the Global Alliance for TB Development (TB Alliance), which is working to discover and develop better, faster-acting tuberculosis treatments, holds the promise of dramatically improving how TB treatment is handled, especially in the world's most vulnerable countries.

PLoS ONE, 03 October 2012

In line with the objectives of the United Nations, which has set a goal of drastically reducing the tuberculosis incidence rate by 2015, several initiatives and partnerships were created to deal with this challenge, such as: TB Alliance, launched in 2000; FIND, Foundation for Innovative New Diagnostics, launched in 2003; Stop TB initiative, created by the World Health Organization in 2006. They aim to provide universal access to high quality diagnostic tools and patient-centered treatment that can reduce the human suffering and socio-economic oppression associated with tuberculosis; protect the poor and populations vulnerable to TB, TB/HIV, and drug-resistant TB; and support the development of better tools, including new medicines and the facilitation of their rapid and efficient deployment.

Medcity News, 27 September 2012

A lack of reliable and inexpensive tools to identify infectious diseases is the greatest obstacle to controlling disease in the developing world, according to the Foundation for Innovative New Diagnostics. Cepheid, for one, is making deals to make its tuberculosis testing kit more affordable in developing countries. mBio Diagnostics is one company working on commercializing its first easy-to-use bedside tests for HIV and syphilis.

PLoS ONE, 24 August 2012

At this time, it is not well known what type of commercial sales contracts NTPs have with ICT producers. Further, favorable pricing schemes for the procurement of BD products are facilitated by the Foundation for Innovative New Diagnostics (FIND) in Geneva for the public and private not-for-profit sector in high endemic countries as listed on their website, through which the BD MGITTM TBc Identification Test is available for $2.90 per piece ex works.

Express Pharma, 06 August 2012

According to data provided by the Foundation for Innovative New Diagnostics (FIND), orders from India for GeneXpert test modules, one of the WHO recommended tests provided at concessional prices to countries like India with a high TB burden, showed a steady pick up from six modules through Q3 2010 to 96 in Q1 2012.

BioSpectrum, 30 July 2012

Over the past decade, the involvement of agencies, such as stop TB Partnership's New Diagnostics working group, the WHO, TDR, Foundation for Innovative New Diagnostics (FIND), has led to the resurgence of interest in the development of new diagnostics.

PLoS One, 27 July 2012

Further, the emphasis on new tools in the Global Plan to Stop TB 2006–2015 [149], along with the creation of product development partnerships such as the Foundation for Innovative New Diagnostics (FIND), AERAS, and Global Alliance for TB Drug Development, may have inspired research on new diagnostics and drugs.

Times of India, 19 July 2012

The district tuberculosis centre (DTC) of Beli/TB Sapru hospital will get its first GeneXpert, a device that detects drug resistant tuberculosis in less than two hours, by August end. The cost of the device is around Rs 25 lakh and it is being funded by the Foundation for Innovative New Diagnostics (FIND), an international non-profit organisation working for diagnostic tools.

moneyhub.net, 11 July 2012

The European funded consortium included STMicroelectronics, University of Sienna (Italy), University of Glasgow (United Kingdom), University of London (United Kingdom), Samara Oblast TB Service (Russian Federation), National Reference Center for Mycobacterium (Germany), University Hospital of Lung Diseases (Albania), National Centre for Infectious and Parasitic Diseases (Bulgaria), and Foundation for Innovative New Diagnostics (Switzerland).

DECCAN Chronicle, 17 June 2012

TB can be confirmed in just two hours, which earlier took nearly two to six months. A Rs.10 lakh worth Gene Xpert, a device that detects drug resistant TB in less than two hours was installed at the two areas. Foundation for Innovative New Diagnostics (FIND), an international non-profit working for diagnostic tools, donated funds for setting up the device.

The Telegraph, 06 June 2012

What is GeneXpert? It is a small machine — about the size of a microwave oven — that fits easily on a small table. It has four cartridges, which means four tests can be run at a time. However, there are larger versions with 100-cartridge capacity. The machine has been developed by a US-based company in association with Foundation for Innovative New Diagnostics (FIND), an international organisation co-funding TB eradication mission worldwide.

The Hindu, 20 May 2012

Lok Sabha member, Botcha Jhansi Lakshmi, launched the RNTCP (Revised national tuberculosis control programme) in association with FIND (Foundation for Innovative New Diagnostics), CBNAAT (cartridge-based nucleic acid amplification testing) project at District TB Control Centre here on Saturday.

Science Speaks: HIB & TB News, 30 April 2012

Highlighting the importance of government partnerships with other entities, Dr. Javier Guzman of Policy Cures discussed the GeneXpert MTB/RIF rapid TB diagnostic. In 2006, the Foundation for Innovative New Diagnostics (FIND) reached an agreement with GeneXpert manufacturer Cepheid to expand their diagnostic platform to include TB, utilizing funding from the National Institute of Allergy and Infectious Diseases (NIAID) at NIH and the Bill & Melinda Gates Foundation.

HindustanTimes, 28 April 2012

Doctors said nearly 10% of MDR patients die before treatment can start. "This device reduces the diagnosis time from eight weeks to six hours for the patient and treatment can start almost immediately. It also stops transmission in the community," said Dr Zarir Udwadia, consultant chest physician, Hinduja Hospital. "We have been able to screen more than 700 people in a month and 10 more sites are near completion," said Dr Neeraj Raizada medical officer, Foundation for Innovative New Diagnostics.

PLoS NTD, 24 April 2012

A novel approach to bridging the gap between demonstrating a technically satisfactory diagnostic assay, and bringing the product in question to the market entails the formation of organisations specifically tasked with this mission. The foremost example of such a Product Development and Implementation Partnership (PDIP) is the Foundation for Innovative New Diagnostics (FIND), an organisation that focuses on a small number of diseases including TB, sleeping sickness, and malaria.

FOX5 News, 27 March 2012

FRANKLIN LAKES, N.J., March 27, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) and FIND (Foundation for Innovative New Diagnostics) have announced a new collaboration to promote access to early and accurate diagnosis of multidrug-resistant tuberculosis (MDR-TB) among HIV-infected patients and other vulnerable populations in India, a country that accounts for nearly 25 percent of TB cases globally.

IBN Live, 25 March 2012

Accredited by the National TB Institute and Central TB Division, the LPA would enable test results in two to three days as against three months taken by the conventional solid culture method. The LPA has been installed by the State Government in association with the Foundation for Innovative New Diagnostics (FIND).

Daily News & Analysis, 23 March 2012

Maharashtra’s tuberculosis department in association with FIND (Foundation for Innovative New Diagnostics), an organisation based in Delhi, will launch a pilot project on World Tuberculosis Day.

The Times of India, 23 March 2012

The cost of the device is around Rs 10 lakh and is funded by the Foundation for Innovative New Diagnostics, an international non-profit working for diagnostic tools.

HindustanTimes, 21 March 2012

The device will be installed at 17 other sites in India for a similar feasibility study under the national TB programme. Most of these sites will be operational in the coming two months. The cost of the device is around Rs 10 lakh and is funded by the Foundation for Innovative New Diagnostics (FIND), an international non-profit working for diagnostic tools.

IRIN, 06 March 2012

And in communities where malaria infections have dropped (mainly due to prevention and treatment), the parasite level can also be so low as to not show up in tests, noted David Bell, head of malaria diagnostics at the Geneva-based research organization, Foundation for Innovative New Diagnostics (FIND).

All Africa, 09 February 2012

The Gates Foundation is partnering on this program with the Foundation for Innovative New Diagnostics (FIND), which will help monitor the grant portfolio and supply clinical TB samples from developing countries, and the Canadian Institutes of Health Research (CIHR), which is co-funding one of the grants.

2011

CityBizList, 30 December 2011

A recent report from FIND Diagnostics and the World Health Organization, for instance, suggests that the demand for a tuberculosis diagnostic test exceeds 750 million tests annually, with nearly 200 million tests needed annually in point-of-care formats.

PRWEB, 18 December 2011

FIND (Foundation for Innovative New Diagnostics), a Geneva-based not-for-profit, and Global BioDiagnostics Corp. (GBD), a US-based biotechnology company commercializing potentially breakthrough technology to diagnose tuberculosis (TB), announced an extension of their Phase 1 Co-Development Agreement aimed at developing a rapid, low-cost and simple test for the detection of active TB in a Point-of-Care (POC) setting.

SciDev.Net, 16 December 2011

Although Mark Perkins, chief executive officer of the Foundation for Innovative New Diagnostics (FIND), welcomed the development, he said that developing rapid diagnostic products in general may not be easy. "There are significant technical challenges … that have not been overcome despite substantial private sector investment," he said.

BioSpectrum, 15 December 2011

A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis (TB).

Fair-News.de, 08 December 2011

Dr. Helge Braun, Parliamentary State Secretary at the BMBF,  said "With the three selected PDPs, Germany supports the most promising initiatives in the fight against neglected and poverty-related diseases...The BMBF funded PDPs are: Drugs for Neglected Diseases (DNDi) with drug development against African sleeping sickness, visceral leishmaniasis, Chagas disease and worm infections; Foundation for Innovative New Diagnostics (FIND) to develop a diagnostic platform for four parasitic diseases (African sleeping sickness, Chagas disease, leishmaniasis and malaria); and European Vaccine Initiative (EVI) to develop a malaria vaccine for pregnant women.

Congress Blog, 01 December 2011

Successes are starting to come in. Among them, a new tool to diagnose dangerous drug-resistant tuberculosis. This machine, called GeneXpert, came from technology first developed by the U.S. military in its efforts to protect U.S. postal workers from anthrax. Now, after an effort coordinated by the PDP group Foundation for Innovative New Diagnostics, the GeneXpert can detect drug-resistant TB in two hours, compared to an older test taking more than two months.

The Guardian, 21 November 2011

"As RDTs were introduced, it became clear that there was nowhere near as much malaria in many areas as people thought," says Dr David Bell, the head of the malaria diagnostics programme at the Geneva-based Foundation for Innovative New Diagnostics (FIND). "Everyone who had a fever used to be classified as having malaria, and now maybe 20% of those people have malaria, and 80% have something else. People have to start thinking differently about the importance of accurate diagnosis," he says.

Today.AZ, 20 November 2011

This year, the Ministry of Justice and the Swiss Foundation for Innovative New Diagnostics (FIND) signed a contract to further improve and modernize bacteriological services in the specialized medical facilities, he said.

PBS Newshour, 16 November 2011

One of those is the espresso maker, or GeneXpert, which grew out of a collaboration among partners put together by the Foundation for Innovative New Diagnostics in Geneva.

Medcompare, 09 November 2011

The Foundation for Innovative New Diagnostics (FIND) supported the study financially and had a role in data interpretation and writing the manuscript.

The University of Queensland News, 07 November 2011

UQ School of Veterinary Science researcher Dr Zablon Njiru has been trialing simple diagnostic tests for devastating Neglected Tropical Diseases diseases such as Buruli ulcer and Human African Trypanosomiasis (sleeping sickness) as well as animal trypanosomiasis. His work in many African countries has been supported by a range of organisations including the Foundation for Innovative New Diagnostics (FIND) based in Geneva, the International Atomic Energy Agency (IAEA), Vienna, and the UBS Optimus Foundation in collaboration with the Stop Buruli Initiative.

BBC-News in pictures, 20 October 2011

Nowesele Phandle, a village health worker and horse rider, has a key role in the latest effort to track down TB patients who would otherwise have never been treated. Supported by a grant from the Stop TB Partnership's TB REACH initiative, the Foundation for Innovative New Diagnostics (FIND) is using horse riders to collect the sputum samples needed to diagnose TB from patients in the most far flung parts of the country.

AfricaFocus, 20 October 2011

Examples include the Medicines for Malaria Venture, the Foundation for Innovative New Diagnostics, or FIND, the Innovative Vector Control Consortium, and the Malaria Vaccine Initiative.

Marketwire, 11 October 2011

Increased funding for infectious disease diagnostics by groups such as the Gates Foundation, the Program for Appropriate Technology in Health (PATH, Seattle, WA) and The Foundation for Innovative New Diagnostics (FIND, Geneva, Switzerland) is helping to develop a new generation of sophisticated test platforms that are designed to meet the needs of low resource environments (electricity, water, refrigeration, etc.).

LabMedica.com, 05 October 2011

The FIND organization has been working in partnership with the Eiken Chemical Company (Tokyo, Japan) over the past six years to develop LAMP for a range of diseases, including tuberculosis, HAT and malaria. This is in line with FIND's focus on developing multipurpose platform technologies that can be used by health workers to detect many diseases with a single instrument.

Times of Malta, 22 September 2011

The Loop-mediated Isothermal Amplification test is “designed to be suitable for use in rural African settings where the disease is most common,” the Geneva-based Foundation for Innovative New Diagnostics and Japanese diagnostics company Eiken said in a press release.

Rwanda news agency, 19 September 2011

La Fondation pour l'innovation de nouveaux tests diagnostics (FIND, sigle en anglais), un organisme spécialisé dans la recherche médicale qui est basé à Genève a annoncé lundi avoir isolé une molécule capable de détecter " rapidement" une nouvelle maladie mystérieuse du sommeil qui touche notamment les populations de la sous-région des Grands Lacs dont le Rwanda, a établi l'Agence Rwandaise d'Information (ARI).

Express Pharma, 19 September 2011

The event was also supported by Bill & Melinda Gates Foundation, Foundation for Innovative New Diagnostics, International Centre for Genetic Engineering and Biotechnology (ICGEB), India & Stop TB Partnership as the technical partners while the Association of Biotechnology Led Enterprises (ABLE) and Confederation of Indian Industry (CII) were the industry partners.

Libération, Maroc, 19 September 2011

Ce test Lamp (Loop-mediated isothermal amplification) pour la trypanosomiase "promet une amélioration considérable de la capacité de confirmer un diagnostic de la maladie du sommeil, même lorsque les parasites sont présents en nombre restreint, grâce à la détection de l'ADN du parasite dans les échantillons des patients", déclarent dans un communiqué reçu à Dakar la fondation Find et la société japonaise Eiken Chemical Co.Ltd, spécialisées dans les diagnostics médicaux, qui ont conduit les travaux pendant six ans.

Sidwaya, 19 September 2011

La Foundation for innovative new diagnostics à but non lucratif (FIND), basée à Genève, et la société de diagnostics japonaise Eiken ont annoncé le 15 septembre dernier, qu’un test moléculaire de nouvelle génération, conçu spécialement pour la maladie du sommeil - une maladie parasitaire mortelle, aussi appelée Trypanosomiase humaine africaine (THA) - est prêt à être utilisé dans des études accélérées sur le terrain, dans plusieurs sites en République démocratique du Congo et en Ouganda.

Research News, 16 September 2011

Designed to be suitable for use in rural African settings where the disease is most common, the LAMP test promises to dramatically improve the ability to confirm a diagnosis of sleeping sickness - even when parasites are present in low numbers - through detection of the parasite's DNA in patient samples. FIND is also exploring LAMP's utility as a tool to confirm cure after treatment of HAT, which would significantly reduce the follow-up period, and could eliminate the need for repeated lumbar punctures

SlateAfrique, 16 September 2011

C’est là que se situe la nouveauté du «premier test moléculaire de terrain». Cette avancée résulte d’un partenariat public privé réunissant la fondation à but non lucratif Find, basée à Genève, et la société de diagnostics japonaise Eiken.

GenomeWeb PCR Insider, 15 September 2011

HAT is the latest disease focus of an ongoing collaboration between FIND and Eiken to develop LAMP-based point-of-care molecular diagnostics, joining similar efforts for tuberculosis and malaria, Lakshmi Sundaram, an advocacy officer for FIND, told PCR Insider this week.

Agence France Presse, 15 September 2011

The LAMP (Loop-mediated Isothermal Amplification) test is "designed to be suitable for use in rural African settings where the disease is most common," the Geneva-based Foundation for Innovative New Diagnostics (FIND) and Japanese diagnostics company Eiken said in a press release.

CBS News Healthwatch, 15 September 2011

"The proper diagnosis of this disease is extremely important," said Sylvain Biéler of the nonprofit Foundation for Innovative New Diagnostics (FIND) that is supporting the Japanese company's efforts. "Because if it is not diagnosed and treated it is always fatal."

Voice of America, 14 September 2011

Ndung’u is head of the Human African Trypanosomiasis and Neglected Diseases Program at FIND, the Foundation for Innovative New Diagnostics. He’s the former Chief Research Officer at the Kenya Agricultural Research Institute. He said, “The seriousness of this disease is that any person who gets infected and does not receive treatment eventually dies.”

Investor's Business Daily, 12 September 2011

But Cepheid's highest-profile project is quite different. A few years ago it joined with the nonprofit Foundation for Innovative New Diagnostics, or FIND, to develop a better tuberculosis test.

New York Times, 12 September 2011

The new test, developed by Eiken Chemical Company, works on standard current but probably can be modified to run on a car battery or even solar power, said Joseph Ndung’u, head of sleeping sickness research for the Foundation for Innovative New Diagnostics.

Research!America, 08 September 2011

Research!America, an Alliance for Discoveries in Health, recently published a fact sheet highlighting California's vibrant global health sector. A new diagnostic test has recently been developed as a result of a unique partnership between Sunnyvale-based diagnostics company Cepheid and the Foundation for Innovative New Diagnostics. Endorsed by the World Health Organization in late 2010, over 30 countries have already adopted the test. www.researchamerica.org/global_health

Nature News, 23 August 2011

This kind of development depends on basic research into TB. The Bill & Melinda Gates Foundation is investing a lot of money into this field, as are other groups, such as the Foundation for Innovative New Diagnostics in Geneva, Switzerland, the US National Institutes of Health in Bethesda, Maryland, academics and industry. The hope is that we will have a cheap, accurate and rapid test in about five years.

Pharma Express, 05 August 2011

The conference sponsor is McGill University & Global Health Strategies, while technical partners are the Bill & Melinda Gates Foundation, Foundation for Innovative New Diagnostics, International Centre for Genetic Engineering and Biotechnology (ICGEB), India & Stop TB Partnership.

Science Watch, 02 August 2011

Catharina Boehme talks with ScienceWatch.com and answers a few questions about this month's Fast Breaking Paper in the field of Clinical Medicine.

SciDev.Net, 02 August 2011

Mark Perkins, chief scientific officer at the Foundation for Innovative New Diagnostics (FIND), told SciDev.Net that several alternative tests were in the pipeline. For example, FIND is working on a test to detect TB in urine that could be tested in 2012.

SFGate, 31 July 2011

David Bell, head of the malaria program at the Foundation for Innovative New Diagnostics in Geneva, says Lifelens is promising but cautions that it has a long road ahead.

Bloomberg Businessweek, 28 July 2011

David Bell, head of the malaria program at the Foundation for Innovative New Diagnostics in Geneva, says Lifelens is promising but cautions that it has a long road ahead. Disposable tests are already in wide use, and others are developing diagnosis technologies, including a DNA-based one that could, like Lifelens, test for multiple illnesses. Only “one or two” of the new techniques will catch on, he says.

mediLexicon, 26 July 2011

The BMGF supported the Foundation for Innovative New Diagnostics (FIND), which was involved in the development of the Xpert MTB/RIF assay.

RehabManagement, 25 July 2011

Cellestis is proud to be exploring opportunities to enhance the global effort to eliminate TB. Cellestis is an industry partner of FIND (the Foundation for Innovative New Diagnostics) and the Stop-TB Partnership.

SciDev.Net, 11 July 2011

David Bell, head of the malaria diagnostics programme at the Foundation for Innovative New Diagnostics, said manufacturers should explore the problems of faint displays "to ensure the tests work across the whole likely range of parasite densities".

Le Temps, 30 June 2011

"Si ce test, plus simple d'emploi et moins cher que l'actuel, a au moins les mêmes performances, alors notre solution s'imposera, commente Sylvain Bièler, chef du projet à FIND. Elle pourrait être disponible alors sur le marché dès l'année prochaine".

The Guardian, 28 June 2011

The report comes from six different major organisations, including the Malaria Vaccine Initiative and Medicines for Malaria Venture. Speaking to Professor Awa Marie Coll-Seck, executive director of the Roll Back Malaria partnership, which co-ordinates the global effort, I was keen to know whether this means that the mosquito-borne disease that kills 750,000 a year – mostly small children – in developing countries is on the way out.

AlertNet, 28 June 2011

Currently, the lion's share of research and development (R&D) funds goes to developing new drugs (38 percent), vaccines (28 percent) and basic research (23 percent), while research into diagnostic tests receives a paltry 1 percent of funding, and product development for controlling malaria-carrying mosquitoes (vector control) just 4 percent. Partly this is because developing and testing new drugs and vaccines is much more costly than developing diagnostics and vector control products, but David Bell, head of the malaria diagnostics programme at the non-profit Foundation for Innovative New Diagnostics (FIND), believes it also reflects donor preferences.

Nature newsblog, 28 June 2011

"There's gross underfunding of diagnostics," says David Bell, head of the malaria diagnostics programme at the Foundation for Innovative New Diagnostics, a body created in 2003 to develop and deploy affordable, innovative diagnostics in poorer countries. Diagnostics are crucial to underpinning malaria control efforts generally, he points out, but their importance isn't as visible as it is for drugs and vaccines: "diagnostics are harder to sell," he says.

Express Pharma, 16 June 2011

The event will be hosted by St John’s Research Institute, Bangalore, India and sponsored by McGill University & Global Health Strategies. Bill & Melinda Gates Foundation, Foundation for Innovative New Diagnostics, International Centre for Genetic Engineering and Biotechnology (ICGEB), India & Stop TB Partnership are the technical partners...

Ciencieas Medicas News, 04 June 2011

The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in controlled studies, but no performance data exist from district and subdistrict health facilities in tuberculosis-endemic countries.

Mail & Guardian Online, 10 May 2011

Slideshow about the unveiling of GeneXpert on World TB Day in South Africa, including FIND CEO describing potential of this technology for use in viral load testing, as well as sexually transmitted diseases. 

MTB europe, 04 May 2011

The project has established working relationships with the Foundation for Innovative New Diagnostics (FIND) and the grantee and his team are consortium members of the TB Clinical Diagnostics Research Consortium led from Johns Hopkins University of USA.

mediLexicon, 04 May 2011

A coalition of 30 leading global health organizations that work on vaccines, drugs, and other tools and technologies that save lives today released a list of recommendations for US policymakers and regulators, calling for acceleration of scientific innovations and streamlining the approval of safe and affordable inventions in order to save more lives around the world...

Advance, 02 May 2011

The molecular diagnostics company developed the test over 4 years with research assistance and underwriting in a partnership with the Foundation for Innovative New Diagnostics (FIND), the University of Medicine and Dentistry of New Jersey (UMDNJ) and the National Institute for Allergy and Infectious Diseases (NIAID).

Cordis Wire, 27 April 2011

The project has established working relationships with the Foundation for Innovative New Diagnostics (FIND) and the grantee and his team are consortium members of the TB Clinical Diagnostics Research Consortium led from Johns Hopkins University of USA.

Medicaldevice-network.com, 26 April 2011

The National Health Laboratory Service of South Africa is examining the possibilities of rolling out GeneXpert testing for routine services. The test was co-developed by Cepheid and Foundation for Innovative New Diagnostics, with additional funding support from the US National Institutes of Health and technical support from the University of Medicine and Dentistry of New Jersey.

PLoS ONE community blog, 25 April 2011

Earlier this month, the Head of Malaria at the Foundation for Innovative New Diagnostics (FIND) in Geneva, Switzerland, David Bell, and colleagues from the Ministry of Health of Senegal, FIND and WHO published a paper on the Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests.

Times Wellness.com, 25 April 2011

The Roll Back Malaria (RBM) Case Management Working Group has substantially contributed to ‘Good procurement practices for malaria Rapid Diagnostic Tests’, to be published by WHO. This is a multi-agency operational manual for malaria RDT policy implementation at national level, coordinated by the Foundation for Innovative New Diagnostics (FIND); and an inter-agency operation manual for universal access to malaria diagnostics, coordinated by WHO's Global Malaria Programme.

ASNS News, 25 April 2011

The World Health Organization (WHO) has issued recommendations on the procurement of RDTs, based on independent comparative performance data published by WHO, TDR and the Foundation for Innovative New Diagnostics (FIND).

Financial Times, 21 April 2011

To help establish some coherence, the World Health Organization started publishing data that compared the performance of different kits. Additionally the agency, together with the Foundation for Innovative Diagnostics (Find), offers a service to test RDTs that have already been purchased. Clearer guidelines on what to expect from them now informs donors' procurement plans.

GenomeWeb Daily News, 21 April 2011

The study, led by clinical researchers from the Foundation for Innovative New Diagnostics, found that Cepheid's Xpert MTB/RIF molecular test, when administered to patients in decentralized laboratories in the developing world, had sensitivity and specificity comparable to the test's performance in previous studies in more centralized reference laboratories.

StopTBPartnership, 21 April 2011

In Lesotho, the Foundation for Innovative New Diagnostics is using a unique combination of horseback riders and mobile phone text messaging to reach people in remote mountainous villages.

MediLexicon, 20 April 2011

The project has established working relationships with the Foundation for Innovative New Diagnostics (FIND) and the grantee and his team are consortium members of the TB Clinical Diagnostics Research Consortium led from Johns Hopkins University of USA. The team are also co-investigators on the EDCTP sponsored TB-NEAT consortium led by Professor Keertan Dheda. Funding from the Wellcome Trust will allow extension of the project to a second laboratory site and, in particular, to the follow up period beyond the term of this EDCTP grant. 

Pharmaceutical Online, 20 April 2011

Examples of such PPPs include the WHO's Special Programme for Research and Training in Tropical Diseases (WHO/TDR), the Drugs for Neglected Diseases initiative (DNDi), the Medicines for Malaria Ventures (MMV), the Global Alliance for TB Drug Development (TB Alliance), the Institute for OneWorld Health (iOWH), the Malaria Vaccine Initiative (MVI) and the Foundation for Innovative New Diagnostics (FIND).

The Telegraph, 20 April 2011

It is believed that the test, which was jointly developed by US-based Cepheid Inc and Switzerland’s Foundation for Innovative New Diagnostics (FIND), can potentially cut delays in diagnosis and treatment of the disease, reducing TB-related morbidity and mortality significantly.

US News & World Report, 19 April 2011

Three African health ministers make the case for consigning TB to medical history. Dr. Aaron Motsoaledi, Dr. Mphu Ramatlapeng, and Mr. Benedict Xaba are, respectively, the ministers of health from South Africa, Lesotho, and Swaziland.

DGNews, 18 April 2011

Catharina Cora Boehme, MD, Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland, and colleagues recruited 6,648 participants aged 18 years and older presenting with cough lasting at least 2 weeks to urban health centres in South Africa, Peru, and India, drug-resistance screening facilities in Azerbaijan and the Philippines, and an emergency room in Uganda.

BioValley Basel, 14 April 2011

Collaborating with the Foundation for Innovative New Diagnostics to ensure access to improved tuberculosis (TB) diagnostics in resource-limited settings highly burdened by drug-resistant TB. Faster, accurate diagnosis of TB reduces the time spent on inappropriate and ineffective patient treatment, which can lead to further drug resistance.

BioSpectrum, 13 April 2011

EXPAND TB is a five-year project targeting 27 countries, launched in 2008 and implemented by the WHO, the Foundation for Innovative New Diagnostics (FIND), the Stop TB Partnership’s Global Drug Facility (GDF) and the Global Laboratory Initiative (GLI) with financial support from UNITAID.

Lab Bulletin, 06 April 2011

For the efficient and rapid detection of tuberculosis bacteria, the World Health Organization (WHO) now recommends LED-fluorescence microscopy. With Primo Star iLED Carl Zeiss developed, in cooperation with FIND (Foundation for Innovative New Diagnostics), a microscope aligned for this application.

IRIN, 28 March 2011

1. GeneXpert: The two-hour TB test released in 2010 is a joint project by Cepheid, a diagnostic products manufacturer, the Foundation for Innovative New Diagnostics (FIND), a non-profit organization, and the University of Medicine and Dentistry of New Jersey, in the US.

India Vision, 26 March 2011

Over 1,700 patients were screened at five sites across the world, including in Mumbai, using this PCR diagnostic kit developed through a partnership between Cepheid and Foundation for Innovative New Diagnostics (FIND), the University of Medicine and Dentistry of New Jersey, the Bill and Melinda Gates Foundation and the National Institutes of Health (US).

IT Director, 24 March 2011

On World TB Day, Lanner has announced that the Liverpool School of Tropical Medicine will use its WITNESS simulation software to model the patient and health system outcomes in Tanzania of GeneXpert[ii], a revolutionary new technology which cuts tuberculosis (TB) diagnosis from days to hours, helping to combat the spread of the disease. [v] FIND negotiated prices

Financial Times, 24 March 2011

More than 20 countries have received the new test, according to the Foundation for Innovative New Diagnostics (Find), one of Xpert's developers. Its advocacy officer, Lakshmi Sundaram says uptake will partly depend on how "flexible and proactive" large donors are.

AlertNet, 24 March 2011

In 2010, the Foundation for Innovative New Diagnostics (FIND) released the Xpert MTB/RIF TB point-of-care test, which detects TB and rifampicin resistance within two hours.

Bio-Medicine, 21 March 2011

Beginning March 21, for each visitor to www.bd.com/fightTB, BD will donate one BD BACTEC™ MGIT™ tube to one of the Company's TB collaborating partners, FIND (Foundation for Innovative New Diagnostics) or the Earth Institute at Columbia University, up to 20,000 tubes.

ACN, 02 March 2011

FIND (Foundation for Innovative New Diagnostics), a Geneva-based not-for-profit, and Global BioDiagnostics Corp. (GBD), a US-based start-up biotechnology company formed to commercialize potentially breakthrough technology to diagnose tuberculosis (TB), announced a collaboration to develop a rapid, low-cost and simple test for the detection of active TB in a Point-of-Care (POC) setting.

PR Newswire, 23 February 2011

As the first showcase of euSEND, three projects are being initiated with FIND (Foundation for Innovative New Diagnostics), a not-for-profit foundation focusing on improving the diagnosis of diseases in developing countries. The projects will focus on leishmaniasis, trachoma and tuberculosis. Other partners involved are Leiden University Medical Center and the Royal Tropical Institute (KIT). 

Bioscience Technology, 16 February 2011

Case in point: Research led By David Alland, MD, at the University of Medicine and Dentistry of New Jersey (UMDNJ)-together with the Foundation for Innovative New Diagnostics (FIND), the National Institutes of Health (NIH) and the manufacturing company Cepheid-spawned a new diagnostic test that tells whether a person has tuberculosis and whether it is a drug-resistant strain of the deadly disease in under two hours.

Doctissimo.ch, 04 February 2011

"Il y a eu une forte volonté de lever tous les obstacles, y compris financiers, susceptibles de compromettre le déploiement de cette nouvelle technologie, reconnaît le Dr Giorgio Roscigno, Directeur général de la Fondation pour des outils diagnostiques nouveaux et novateurs (FIND).

Newsblaze, 03 February 2011

India's largest network of people living with HIV held a meeting recently with Cepheid, and Foundation for Innovative New Diagnostics (FIND), the co-developers of a new rapid 100 minute TB diagnostic test (GeneXpert), to push for quick roll-out and better costing. Representatives from India's national TB programme officially called the Revised National TB Control Programme (RNTCP) also attended the meeting.

San Francisco Business Times, 03 February 2011

Cepheid (Nasdaq: CPHD) and FIND (Foundation for Innovative New Diagnostics) today announced a new collaboration to accelerate the development of a rapid molecular test for the measurement of human immunodeficiency virus (HIV) viral load.

Genetic Engineering & Biology News, 03 February 2011

FIND (Foundation for Innovative New Diagnostics) has agreed to put $5 million into a collaboration with Cepheid that aims to speed the development of a molecular test for measuring HIV viral load, for use on Cepheid’s GeneXpert® platform.

Technology Review, 31 January 2011

Die Stiftung Foundation for Innovative New Diagnostic (FIND) mit Sitz in der Schweiz hat das Verfahren entwickelt, unterstützt von Forschern aus Industrie, Hochschulbereich und Non-Profit-Organisationen. Die Technik basiert auf einem Mikrofluidiksystem, bei dem die Probe durch kleinste Kanäle geleitet wird. Der Test beginnt mit der Beimischung einer einfachen chemischen Mischung aus Natronlauge und Alkohol. So werden lebende Erreger abgetötet. Der Vorteil: Weitergehende Maßnahmen zur Biosicherheit sind nicht mehr notwendig.

VaccineNewsDaily, 07 January 2011

Switzerland's Foundation for Innovative New Diagnostics has developed a new device to test specimens for drug-resistant tuberculosis that reduces the typical cell culture testing time from two weeks to two hours.

MedGadget, 06 January 2011

A Swiss group, The Foundation for Innovative New Diagnostics, has come up with a better way. The sputum sample is first treated with sodium hydroxide and alcohol, killing any TB, and the sample is fed into a small device which analyzes the DNA and gives a simple report regarding the presence of TB and the resistance status of the organism.

2010

Pregonline, 23 December 2010

El Dr. Giorgio Roscigno, consejero delegado de la Fundación para la Obtención de Medios de Diagnóstico Innovadores (FIND), una de las dos organizaciones que participaron en la prueba, señaló que han reducido el costo de la tecnología para hacerla más accesible a los países en desarrollo.

Technology Review, India edition, 21 December 2010

The Foundation for Innovative New Diagnostics, the Switzerland-based organization that spearheaded the project, has already tested the device in clinics around the world. "Users have uniformly said that the test was simpler than microscopy," says Mark Perkins, FIND's chief scientific officer. "It's a huge leap forward," says Karen Steingart, a tuberculosis researcher at the University of California, San Francisco, who compares the test to cell phones in terms of potential impact.

AP, 21 December 2010

Foundation for Innovative and New Diagnostics officials said Wednesday the test will be sold to more than 100 developing countries at a 75 percent discount - about $17 (euro12.72), instead of $67 (euro50.14).

Dark Daily, 20 December 2010

It’s big news when an international health body endorses a new proprietary clinical laboratory test. That’s why pathologists will be interested to learn that, earlier this month, the World Health Organization (WHO) publicly recommended that nations incorporate a new rapid molecular test for tuberculosis into their disease testing programs.

NowPublic, 19 December 2010

The ITBS 2010 is being organized by the International Centre for Genetic Engineering and Biotechnology (ICGEB) in New Delhi, India (16-17 December 2010) with support from the Aeras Global TB Vaccine Foundation, Bill and Melinda Gates Foundation and Foundation for Innovative New Diagnostics (FIND).

The Medical News, 13 December 2010

The driving force behind the rapid tuberculosis test that received World Health Organization endorsement this week is Dr. David Alland, chief of the Division of Infectious Disease at UMDNJ-New Jersey Medical School.

Science Speaks, 10 December 2010

This test was co-developed by GHTC member Foundation for Innovative New Diagnostics (FIND) in conjunction with several other groups that received NIH funding to develop this ground-breaking tool. The development of this test offers a glimpse into the true nature of innovation and the value of creative thinking: it was initially developed for the U.S. Postal Service to help postal workers check for anthrax contamination in the mail.

NJ.com, 10 December 2010

The test machines, cartridges and technology are manufactured by Cepheid, a California-based genetic testing company, with help from the international non-profit Foundation for Innovative New Diagnostics. The start-up money for the research came from the National Institutes of Health and the Bill and Melinda Gates Foundation, but it also came with a catch: that the cost of the machines be made affordable to the neediest parts of the world.

IRIN, 09 December 2010

The UN World Health Organization (WHO) has endorsed a new rapid test for tuberculosis that could save millions of lives through early diagnosis of the disease. TB killed an estimated 1.7 million people globally in 2009...Developed by the Foundation for Innovative New Diagnostics (FIND), a non-profit organization based in Switzerland, the test is also able to detect drug-resistant forms of tuberculosis and TB complicated by HIV infection.

Science Insider, 09 December 2010

The new TB test was developed by Cepheid, a company in Sunnyvale, California, in partnership with the Foundation for Innovation New Diagnostics (FIND) and the University of Medicine and Dentistry of New Jersey. It's a "fully automated" system, which even health workers in developing countries can operate after a minimum of training, says FIND Chief Executive Officer Giorgio Roscigno.

Reuters, 08 December 2010

"There has been a strong commitment to remove any obstacles, including financial barriers, that could prevent the successful roll-out of this new technology," said Giorgio Roscigno, FIND's chief executive. "For the first time in TB control, we are enabling access to state-of-the-art technology simultaneously in low, middle and high income countries."

Africa Science News Service, 08 December 2010

Co-developer FIND (the Foundation for Innovative and New Diagnostics) is announcing today it has negotiated with the manufacturer, Cepheid, a 75% reduction in the price for countries most affected by TB, compared to the current market price.

The Guardian, 08 December 2010

The test been developed by the Foundation for Innovative New Diagnostics (FIND) with the private company Cepheid and the University of Medicine and Dentistry of New Jersey. The funding came from the National Institutes of Health in the US and the Bill and Melinda Gates Foundation.

ABC news, 08 December 2010

Foundation for Innovative and New Diagnostics officials said Wednesday the test will be sold to more than 100 developing countries at a 75 percent discount — about $17 (euro12.72), instead of $67 (euro50.14).

La Repubblica, 07 December 2010

Giorgio Roscigno ci ha sempre creduto: "La nostra ossessione è di avere test diagnostici affidabili e sicuri in qualsiasi Paese: insomma che non vi siano, o siano ridotti al massimo, gli errori del tecnico che possono falsare un esame."

University Affairs, 06 December 2010

2006/ Collaboration begins between WHO and the Foundation for Innovative New Diagnostics to develop and evaluate new diagnostic tests for human African sleeping sickness.

Global Health Advocates India, 30 November 2010

The test, Xpert MTB/RIF, has been developed by Cepheid (US based) in collaboration with the Foundation for Innovative New Diagnostics (FIND), the University of Medicine and Dentistry of New Jersey (UMDNJ), and the US-run National Institute of Allergy and Infectious Diseases (NIAID). A review of this new diagnostic tool has appeared in the New England Journal of Medicine (NEJM) in September 2010.

Bio Techniques, 23 November 2010

In 2003, Mark Perkins and his colleague Giorgio Roscigno received funding from the Gates Foundation to start the Foundation for Innovative New Diagnostics (FIND). Perkins had been leading the development of new diagnostic assays for infectious diseases at the World Health Organization; Roscigno was the strategic development director of the Global Alliance for Tuberculosis (TB) Drug Development.

Today.Az, 20 November 2010

This year, the Ministry of Justice and the Swiss Foundation for Innovative New Diagnostics (FIND) signed a contract to further improve and modernize bacteriological services in the specialized medical facilities, he said.

Unicef - Uganda, 19 November 2010

Following demos of some of the most widely used M4D applications, UNICEF programmers ran a ‘trade fair’ that included members of the Uganda Linux User Group, the Foundation for Innovative New Diagnostics and FrontlineSMS, as well as senior programmers from Makerere University.

Deccan Chronicle, 18 November 2010

Currently, the city has one such lab. A delegation from Unitaid and Foundation for Innovative New Diagnostics (FIND) met Dr P.V. Ramesh, the principal secretary of medical health and family welfare, in this regard on Wednesday.

TropIKA, 16 November 2010

Joseph N’dungu of the Foundation for Innovative New Diagnostics (FIND) is working with partners on a number of projects to develop diagnostic platforms for staging HAT with improved accuracy to guide treatment, and for follow-up to determine treatment success. Special attention is being given to ensuring that the diagnostics are developed with a user friendly format, which does not require lab-trained operators.

The New Yorker, 15 November 2010

In 2008, with funding from the Bill and Melinda Gates Foundation, the Foundation for Innovative New Diagnostics, and the National Institutes of Health, researchers at medical centers throughout the world began to assess the machine’s effectiveness in diagnosing tuberculosis.

Science speaks: HIV & TB news, 12 November 2010

After speaking about new tools to diagnose TB and other diseases, Giorgio Roscigno, MD, walked off the stage at the American Society of Tropical Medicine and Hygiene last week in Atlanta only to face a long line of people waiting to talk with him. He stayed until organizers of the next session finally had to shoo him out of the room.

TropIKA, 04 November 2010

The development of an automated molecular test, called Xpert MTB/RIF, was reported in the New England Journal of Medicine in September. The test can detect TB – and also the presence of resistance to one TB drug, rifampicin – in 90 minutes. It was trialled in five sites – from Lima, Peru to Mumbai, India and South Africa – by the Foundation for Innovative New Diagnostics (FIND), a product development partnership dedicated to developing diagnostic technologies for low-income countries.

IJLTD-The Lancet, 01 November 2010

Recent unprecedented efforts have led to an expanded tuberculosis diagnostic pipeline, and, in September, publication of the performance of Xpert MTB/RIF in a large multicentre trial was heralded as representing a new era in tuberculosis diagnostics. Xpert is the first automated molecular tuberculosis test developed for point-of-treatment use.

TropIKA.net, 27 September 2010

FIND says it has negotiated concessionary pricing for public-sector programmes in low-income countries and is working to further lower the costs of testing. Nevertheless, according to FIND, the costs of instruments and tests will still be considerably higher than those for microscopy.

BioTechniques.com, 24 September 2010

The test was finalized with additional support from the Foundation for Innovative New Diagnostics (FIND), which coordinated the first clinical study.

Ciensias Medicas News, 13 September 2010

The clinical trial was led and supported by the Foundation for Innovative New Diagnostics, a Swiss-based nonprofit organization.

Corriere della Sera, 10 September 2010

In secondo luogo i costi: il test «usa tecnologie sofisticate, che sono costose da produrre», hanno spiegato gli autori. «E anche se il Find (Foundation for Innovative New Diagnostics, l’organizzazione no profit che insieme alla Bill & Melinda Gates Foundation ha finanziato lo studio, ndr) ha negoziato prezzi scontati per i programmi pubblici nei Paesi a basso reddito e sta lavorando per abbassare ulteriormente i costi del test, questi potrebbero rimanere notevolmente più alti rispetto a quelli dell’esame microscopico».

Nursing Practice Blog, 07 September 2010

Cepheid, a California-based diagnostics company; the University of Medicine and Dentistry in New Jersey, and the Foundation for Innovative New Diagnostics, a Swiss-based non-profit group supported by the Gates Foundation collaborated with the United State government to develop this test.

British Medical Journal, 07 September 2010

Giorgio Roscigno, chief executive officer of the foundation, said that it has negotiated with Cepheid so that the cost of the new diagnostic machine and computer to read results could be purchased at a reduced cost by public sector organisations working in low income countries where tuberculosis is endemic.

IRIN, 05 September 2010

An expert committee is meeting in Geneva to review evidence from the FIND study and other research before making a recommendation by the end of September.

World Book and News, 03 September 2010

Less than 4% of results (192 of 5,190 tests in total) yielded indeterminate results, which dropped to 1.2% for repeat tests. "No patient had indeterminate results on all samples tested," Boehme and colleagues reported.

eMaxHealth, 03 September 2010

Catharina C. Boehme, MD, of the Foundation for Innovative New Diagnostics (FIND) in Geneva, Switzerland, and colleagues, reported the results of their study online September 1 in the New England Journal of Medicine.

Medscape Medical News, 02 September 2010

"Global control of tuberculosis is hampered by slow, insensitive diagnostic methods, particularly for the detection of drug-resistant forms and in patients with human immunodeficiency virus infection," write Catharina C. Boehme, MD, from the Foundation for Innovative New Diagnostics in Geneva, Switzerland, and colleagues. "Early detection is essential to reduce the death rate and interrupt transmission, but the complexity and infrastructure needs of sensitive methods limit their accessibility and effect."

HealthDay News, 02 September 2010

For the study, a research team led by Dr. Catharina C. Boehme, of the Foundation for Innovative New Diagnostics in Geneva, Switzerland, used the Xpert MTB/RIF test on 1,730 patients suspected of having drug-sensitive or multidrug-resistant pulmonary tuberculosis. The patients were from Azerbaijan, India, Peru and South Africa.

MedPage Today, 02 September 2010

Sensitivity exceeded 98% in samples from patients with smear-positive Mycobacterium tuberculosis infections and the false positive rate was 0.8%, according to Catharina C. Boehme, MD, of the Foundation for Innovative New Diagnostics (FIND) in Geneva, Switzerland, and colleagues.

AFP, 02 September 2010

"Early, rapid and accurate detection of TB, including identification of drug-resistant strains, is critical to effectively treating the disease, reducing secondary resistance, stopping further transmission and saving lives," said Giorgio Roscigno, chief executive officer of the Foundation for Innovative New Diagnostics (FIND), one of the funders of the research.

Forbes, 02 September 2010

The study concluded that Cepheid's Xpert MTB/RIF - an easy-to-use molecular test developed in partnership with FIND and the University of Medicine and Dentistry of New Jersey (UMDNJ), with additional funding from the National Institute of Allergy & Infectious Diseases (NIAID) - provided sensitive and specific detection of tuberculosis and rifampin resistance (a critical marker of multidrug resistance) directly from untreated sputum specimens in less than two hours.

INO.news, 02 September 2010

The government set out to develop a better test with a host of partners: Cepheid, a California-based diagnostics company; the University of Medicine and Dentistry in New Jersey, and the Foundation for Innovative New Diagnostics, a Swiss-based nonprofit group supported by the Gates Foundation.

NIH News, 01 September 2010

The current clinical trial findings are from a study conducted by the Foundation for Innovative New Diagnostics (FIND), a Swiss-based nonprofit organization. NIAID currently supports a partnership project to expand the diagnostic system to detect other resistance markers for extensively drug-resistant TB.

Nature, 01 September 2010

"It's huge," says Giorgio Roscigno, chief executive officer of the Foundation for Innovative New Diagnostics (FIND), a non-profit organization based in Geneva, Switzerland, which conducted the study. "This test has the potential to make the biggest impact ever in TB control."

Reuters, 01 September 2010

"We're very pleased with the outcome," said Mark Perkins, chief scientific officer at the Geneva-based non-profit organization the Foundation for Innovative New Diagnostics (FIND), which worked on the study.

New York Times, 01 September 2010

The government set out to develop a better test with a host of partners: Cepheid, a California-based diagnostics company; the University of Medicine and Dentistry in New Jersey, and the Foundation for Innovative New Diagnostics, a Swiss-based nonprofit group supported by the Gates Foundation.

Bloomberg Businessweek, 01 September 2010

If GeneXpert is recommended by the WHO for use in tuberculosis surveillance and monitoring, demand for the single-use cartridges may be in the range of “hundreds of thousands very soon and in the millions in the next one or two years,” said Giorgio Roscigno, chief executive officer of FIND, in a telephone interview.

Los Angeles Times, 01 September 2010

In the new study reported online Wednesday in the New England Journal of Medicine, a team headed by Dr. Catharina C. Boehme of the Foundation for Innovative New Diagnostics in Geneva, studied specimens from 1,730 patients from Peru, Azerbaijan, South Africa and India who were suspected of having tuberculosis.

LabCiencia con noticias técnicas del laboratorio, 19 August 2010

With the Primo Star iLED, Carl Zeiss is introducing a new fluorescence microscope, which enables the fast and reliable detection of tuberculosis. Together with FIND, the Foundation for Innovative New Diagnostics, which co-developed the microscope, the optics company will be presenting the system at the 39th World Union Conference on Lung Health in Paris.

IRIN News, 07 July 2010

The Foundation for Innovative New Diagnostics, which works with WHO to create quality control standards for rapid tests, recommends spot checking in each batch of tests ordered to ensure the tests were not poorly manufactured, or had been damaged in transit or storage.

Applied Clinical Trials online, 24 June 2010

Cellestis is proud to be exploring opportunities to enhance the global effort to eliminate TB. Cellestis is an industry partner of FIND (the Foundation for Innovative New Diagnostics) and the Stop-TB Partnership.

SciDev Net, 03 June 2010

Technologies that are applicable to more than one disease can deliver diagnostic tools for neglected infectious diseases such as human African trypanosomiasis (sleeping sickness) at little extra cost, say Joseph Mathu Ndung'u and colleagues.

The World Bank - News & Broadcast, 01 June 2010

Through partnerships, parallel grant financing for specialized TB diagnostics has been secured from the International Drug Purchase Facility (UNITAID) through the EXPAND-TB Project which is a collaborative effort of WHO/Global Laboratory Initiative, the Foundation for Innovative New Diagnostics and the Global Drug Facility.

Malaria Journal, 12 May 2010

The authors of this latest assessment stress that, “There are a clear set of criteria related to local conditions that need to be considered in deciding the best diagnostic test for a particular country”. The assessment was undertaken by the Special Programme for Research and Training in Tropical Diseases (TDR), the Foundation for Innovative New Diagnostics (FIND) and WHO’s Global Malaria Programme. It is available from the TDR website.

Stop TB Partnership, 26 April 2010

EXPAND-TB is a UNITAID-funded joint collaboration between FIND, WHO, the Global Laboratory Initiative (GLI) and the Stop TB Partnership Global Drug Facility (GDF). The project aims to narrow the diagnostic gap in MDR-TB control in 27 countries by increasing access to new diagnostic technologies, accompanied by the requisite know-how for technology transfer, and ensuring that new technologies are properly integrated within TB control programmes.

World Health Organization, 23 April 2010

The evaluation programme is co-sponsored by the Foundation for Innovative New Diagnostics (FIND), the Special Programme for Research and Training in Tropical Diseases (TDR), WHO Global Malaria Programme (GMP) and the WHO Regional Office for the Western Pacific.Testing is performed at the US Centers for Disease Control and Prevention (CDC).

Financial Times, 22 April 2010

“It makes it possible to do something that’s not possible for many things sold into developing countries,” says Mark Perkins, chief scientific officer at the Foundation for Innovative New Diagnostics (FIND), one of the organisations behind the WHO’s evaluation study. “And that is to allow ministries of health who don’t have the staff or the capabilities to do this kind of analysis to decide what to buy.”

PR Newswire, 06 April 2010

Cellestis is proud to be exploring opportunities to enhance the global effort to eliminate TB. Cellestis is an industry partner of FIND (the Foundation for Innovative New Diagnostics) and the Stop-TB Partnership.

Financial Times, 24 March 2010

“Most HIV-positive patients with TB might still end up with only a few micro-bacteria in their sputum because they don’t have a good system that can sequester the micro-bacteria,” says Giorgio Roscigno, chief executive of the Foundation for Innovative New Diagnostics (FIND). “So co-infection with HIV has made the disease much more complicated to diagnose.”

Center for Global Health Policy, 24 March 2010

An international collaboration that includes the WHO, the Global Laboratory Initiative, and the Foundation for Innovative New Diagnostics (FIND) is working to upgrade and modernize national TB reference laboratories in 27 developing countries in an effort known as the EXPAND-TB Project...Lesotho Health and Social Welfare Minister Mphu K. Ramatlapeng, who took her post in 2007, marveled in a 2009 interview about the transformation of her national TB laboratory. She said that FIND’s assistance was particularly critical in moving the project ahead...

hivandhepatitis.com, 24 March 2010

WHO estimates that only 7% of MDR-TB cases worldwide were diagnosed in 2008. WHO is currently working with the Foundation for Innovative New Diagnostics (FIND), the Stop TB Partnership's Global Drug Facility (GDF) and the Global Laboratory Initiative (GLI) with financial support from UNITAID in a partnership called EXPAND TB to upgrade laboratories and improve diagnosis.

The Hindu, 15 March 2010

The new diagnostic tools being introduced in the IRL are the latest in TB diagnostics, developed by Switzerland-based Foundation for Innovative New Diagnostics (FIND) and Hain Life Science and now endorsed for use in high TB burden countries by the WHO.

2009

IRIN, 30 October 2009

Non-invasive tests also reduce the potential for HIV exposure, said scientist David Bell at Geneva-based Foundation for Innovative New Diagnostics (FIND). And non-invasive tests are preferable particularly when surveying a disease outbreak, as even a small amount of pain involved in a procedure can be a disincentive for people to seek healthcare.

Campus No 96, 01 October 2009

Le soutien vient de FIND (Foundation for Innovative New Diagnostics), une fondation à but non lucratif basée à Genève, qui oeuvre pour la mise au point de nouveaux outils de diagnostic pour les maladies associées à la pauvreté.

ICAP, 14 September 2009

Ethiopia’s National Laboratory Master Plan spearheaded the renovations, which were supported by ICAP, the Ethiopian Health and Nutrition Research Institute, the President’s Emergency Plan for AIDS Relief/U.S. Centers for Disease Control and Prevention, and the Foundation for Innovative New Diagnostics.

Communiqué de presse, 25 August 2009

Des chercheurs genevois ont trouvé de nouveau moyens de dépister plus précocement l'affection causée par la mouche tsé-tsé.
Tribune de Genève, le 26 aot 2006

TropIKA, 24 August 2009

Several agencies, groups and individuals have contributed to the development of this resource. These include the Foundation for Innovative New Diagnostics (FIND), the Special Programme for Research and Training in Tropical Diseases (TDR), the Global Laboratory Initiative (GLI), and the Public Health Agency of Canada (PHAC).

IRIN, 21 August 2009

David Bell, a scientist at the Geneva-based non-profit Foundation for Innovative New Diagnostics, told IRIN that new approaches were needed to diagnose febrile diseases in addition to malaria. "There needs to be a lot of investment in diagnostics appropriate for this [community] level to guide health workers to at least identify and treat, or refer, those patients who have a non-malarial infection that is likely to kill them. Most African children who die have diseases other than malaria." 

UNAIDS, 18 August 2009

The website has been established by the Stop TB Partnership's New Diagnostics Working Group in collaboration with the Foundation for Innovative New Diagnostics, the Special Programme for Research and Training in Tropical Diseases, the Global Laboratory Initiative and the Public Health Agency of Canada.

Genetic engineering & biotechnology news, 03 August 2009

The Foundation for Innovative New Diagnostics leads the effort on new diagnostic tools that could reduce TB incidence by 13 percent to 42 percent. Diagnostics and treatment go hand-in-hand because new diagnostic tests have an epidemiological effect by moving people to treatment more rapidly. The three diagnostic methods examined in the study achieve their improvements in TB incidence and mortality fairly rapidly. The four-month, two-month, and 10-day novel active disease treatment regimens produce 10 percent, 23 percent, and 27 percent reductions in TB incidence by 2050 compared to 2015.

TropIKA, 31 July 2009

Two initiatives to address the neglect of diagnosis have made an appearance in TropIKA.net during the last few days. The African Network for Drugs and Diagnostics Innovation (ANDi) has announced that it will present its strategy and business plan in October, and the TropIKA.net blog links to an interview with Joseph Ndung’u of the Foundation for Innovative New Diagnostics (FIND) about the search for a new diagnostic test for trypanosomiasis (sleeping sickness).

Nigerian Guardian News, 25 July 2009

Speaking at the event, WHO's Technical Officer, Accessible quality-assured diagnostics, Dr. Jane Cunningham, who was represented by Dr. Caroline Asiimwe (FIND), noted that RDTs have become imperative in combating malaria at community levels, where skilled personnel were not available. She noted that the latest technology in malaria management is cost effective as it usually takes 15 minutes to deliver results. 

Indian express, 20 July 2009

The State Tuberculosis Demonstration and Training Centre (STDC) has recently received the equipment for the MGIT- 960, provided by the Foundation for Innovative New Diagnostics (FIND), Geneva, which will start training staff for the new method from August.

The Australian, 18 July 2009

According to FIND (The Foundation for Innovative New Diagnostics): "Only 19 per cent of the world's TB cases are detected by the most widely used test, sputum smear microscopy, which is at best 40 per cent sensitive. (Over 90 million sputum smear tests a year, according to Nantulya 2006). Technology must move beyond the standard sputum microscopy test discovered in the 1880s if diagnostic rates are to improve.

South African Ministry of Health, WHO Stop TB, 16 July 2009

A Stop TB Partnership delegation on a high-level visit to South Africa was greeted today by Deputy President Kgalema Motlanthe. Members included Irene Koek, Chair of the Stop TB Partnership Coordinating Board; Dr. Marcos Espinal, Executive Secretary of the Stop TB Partnership; Dr. Giorgio Roscigno, CEO of FIND; Dr. Leopold Blanc, Coordinator in the WHO Stop TB Department; and Dr. BAH Keita, Regional Adviser for Tuberculosis for the WHO African Region. They also met at length with Health Minister Dr. Aaron Motsoaledi to discuss the findings of the recent TB programme review led by WHO and several partners and the way forward to accelerate action on TB and TB/HIV.

IRIN, 14 July 2009

Up to tens of thousands of people in Africa who are infected with trypanosomiasis, also known as sleeping sickness, go undiagnosed because the only way to detect the deadly infection is through blood exams and a painful expensive lower back puncture, according to the Geneva-based Foundation for Innovative New Diagnostics (FIND).

TDRnews, 14 July 2009

Among the most ambitious projects to date was the recent evaluation of rapid malaria tests, whose findings were published on 24 May 2009 (see www.who/tdr), shortly before World Malaria Day. Forty-one malaria tests were evaluated at US Centers for Disease Control and Prevention (CDC) laboratories as part of a major collaboration between TDR, WPRO and FIND. The RDTs were subjected to stringent tests to determine not only accuracy but also how well they stand up to tropical temperatures.

Nanotechnology, 09 July 2009

The Primo Star iLED was originally developed together with FIND, the Foundation for Innovative New Diagnostics, for the fast and reliable LED fluorescence based testing of tuberculosis and has been on the market since October 2008. 

SciDev.Net, 26 May 2009

As the need for rapid diagnostic tests (RDTs) rises, manufacturers face the challenge of improving test standards while also increasing supply, says David Bell, head of malaria diagnostics at the Foundation for Innovative Diagnostics (FIND). There is also a growing demand for tests that identify low levels of infection in people without symptoms, adds Bell. This follows a rise in health programmes that aim to eliminate malaria, not just treat patients.

IRIN, 12 May 2009

FIND scientist Ndung'u told IRIN he is sticking with tsetse flies. “Whereas the impact [of our work] on humans may not be so obvious, the link to Africa’s agriculture is what makes tsetse flies so important. With oxen to pull plows, you can produce 10 times more, feed yourself and your children and have enough to sell at the market.” Article en français

IRIN, 11 May 2009

Most African countries have signed the Maputo Declaration pledging to develop and implement national laboratory policies, build laboratory capacity as part of their primary healthcare strategy and set up integrated laboratory networks at the community, district, regional and national levels for quality assurance training and sending samples from one laboratory to the next, said FIND’s Roscigno.

Biospace.com, 07 May 2009

A key objective of Membership is therefore to create strategic relationships with stakeholders in the biotech sector, in particular those who have a common interest in supporting the long-term vision of the CPGR. The CPGR’s immediate focus in the field of biomedicine lies on enabling translational research related to key African diseases such as TB, HIV/AIDS, and malaria, amongst others.

Financials.com, 27 April 2009

The new test, developed in partnership with the Foundation for Innovative New Diagnostics (FIND), the University of Medicine and Dentistry of New Jersey (UMDNJ), and funded by the National Institute of Allergy & Infectious Diseases (NIAID), will leverage the power of Cepheid's GeneXpert(R)System to deliver a highly accurate diagnosis of the disease in less than two hours. Read more Diagnostic TB Test Developed by UMDNJ Physician Expected to Provide More Efficient Results

IRIN, 25 April 2009

World Health Organization (WHO) and the non-profit Foundation for Innovative New Diagnostics (FIND) have released the largest, independent laboratory evaluation of malaria rapid diagnostic tests (RDTs) for World Malaria Day, which shows that while some tests accurately detect even slight traces of malaria in tropical temperatures, others give false results, missing potentially life-saving diagnoses.

Science, 17 April 2009

In the end, the arrangement was a success: In addition to supporting patient treatment, she helped MSF launch a study, funded by the U.S. Centers for Disease Control and Prevention and the Foundation for Innovative New Diagnostics, which brought expensive diagnostic equipment to the laboratory, reducing the time it took to diagnose an MDR TB patient from 8 weeks to 10 days.

IVD Technology Magazine, 16 April 2009

Another group emerging from the TDR program is the Foundation for Innovative New Diagnostics (FIND). In 2003, FIND was launched in conjunction with the Bill and Melinda Gates Foundation, and represents an expansion of ongoing efforts to find and develop new diagnostics for neglected infectious diseases. FIND and the TDR program have developed a joint work plan to deliver new and affordable tools for TB to the public sector. The establishment of these organizations to address specific needs is an example of how the TDR program can initiate new activities in partnership with other organizations.

The Times of India, 24 March 2009

Around 1.1 lakh Indians suffering from tuberculosis are developing drug resistance every year. What's worse, at present, it takes over three months to confirm a single drug resistant case. This has now made the health ministry join hands with Geneva-based Foundation for Innovative New Diagnostics to test new age diagnostic tools that will detect multi-drug resistant TB (MDR-TB) in just two days.

News Blaze, 24 March 2009

Through the Foundation for Innovative New Diagnostics, Small said, molecular diagnostics are becoming available that will report in hours rather than months whether a person has drug-resistant TB. He expects rapid diagnostic tests to be available by 2012.

TropIKA.net, 23 March 2009

Dr Adhanom has also announced, at a press conference in Addis Ababa, the opening of a reference laboratory for the evaluation of rapid diagnostic tests (RDTs) for malaria. The testing centre, to be housed at the Ethiopian Health and Nutrition Research Institute (EHNRI), will join two other centres, one in Cambodia and the other in the Philippines, in a global network of laboratories designated by World Health Organization and the Foundation for Innovative New Diagnostics. The laboratories allow countries that have procured malaria RDTs for use in the public sector to evaluate their quality and performance before they are distributed.

C&EN, 16 March 2009

"It’s a common misconception that diagnostics don’t need to perform as well in the developing world as they do in the developed world," says Mark D. Perkins, a physician and the chief scientific officer at the Foundation for Innovative New Diagnostics, in Geneva. "If anything, the quality of diagnostics in developing countries needs to be even better than those in developed countries," he says.

2008

Daily Monitor, 05 December 2008

Kakaire A. Kirunda

Scientific American, 25 August 2008

Merrill Goozner

Lesotho News, 25 August 2008
Tribune de Genève, 23 June 2008

Alain Jourdan

(english translation)

Tribune Médicale, 20 June 2008

Rédaction

Bilan, 18 June 2008

Fabrice Delaye

(english translation)

Agefi, 11 June 2008

Gaspard Kühn

Voice of America, 10 June 2008

Lisa Schlein

The Guardian Weekly, 05 June 2008

Tatum Anderson

Hindustan Times, 27 April 2008

HT Correspondent

Reuters, 25 April 2008

Martha Kerr

FOX News, 21 April 2008

Katherine Tweed

South Africa Mail & Guardian, 14 April 2008

Belinda Beresford

The Hindu, 12 April 2008

Tamil Nadu

American Thoracic Society, 02 April 2008
PLoS MEdicine, Volume 5, Issue 2, 28 February 2008

Pere P. Simarro, et al.

2007

HDN Key Correspondent Team, 10 November 2007

Kakaire Kirunda, Uganda

Innovations, 01 November 2007

Salmaan Keshavjee, et al.

Nature Methods, 22 October 2007

Robert Grant

Nature Methods, 22 October 2007
Tribune de Genève, 19 September 2007


L'Agefi, 19 September 2007


Calibre, 30 August 2007


SciDevNet, 04 July 2007


MediLexicon, 18 May 2007


Bulletin of the World Health Organization, Volume 85, Number 5, 01 May 2007


Bulletin of the World Health Organization, Volume 85, Number 5, 01 May 2007


Laboratorytalkon, 04 April 2007

Roche Applied Science and the Foundation for Innovative New Diagnostics (Find) will explore development of projects in the area of in-vitro diagnostics (IVD) products for poverty-related diseases.

Nature, 28 March 2007


Aidsmap, 23 March 2007


The Independent on Saturday, 24 February 2007


The Kaiser network, 22 February 2007


Nature, 31 January 2007

This series of papers was written following the Bill and Melinda Gates Foundation's Global Diagnostics Forum

Nature Medicine, 30 January 2007

In November, Johns Hopkins University scientists reported the first successful screening technique based on DNA from saliva or urine samples, rather than from blood. Researchers from the Geneva-based Foundation for Innovative New Diagnostics (FIND) have also devised a DNA-based test that, unlike other molecular tests, does not have to be sent away to a lab.

The New York Times, 22 January 2007

FIND Chief Scientific Officer featured in NY Times article

Medical News Today, 14 January 2007


2006

Tribune de Genève, 14 December 2006


L'Agefi, 12 December 2006


2004

E-MED, 14 June 2004


Clinica 1107, 14 May 2004


2003

The Scientist, 03 June 2003


Clinica 1059, 30 May 2003


Science, 30 May 2003


The Economist, 22 May 2003


Global Alliance for TB Drug Development, 22 May 2003


Bill and Melinda Gates Foundation, 22 May 2003


UNDP / World Bank / WHO - TDR, 22 May 2003


Stop TB Partnership Communiqué - Issue No. 32, 21 May 2003